Vedolizumab Treatment of Refractory Immune Checkpoint Inhibitor Colitis

被引：0
|
作者：
McNally, Bridgette B. [1 ]
Sivakumar, Angiela [1 ]
Haddad, Nael [2 ]
Suchartlikitwong, Sakolwan [1 ]
Aguon, Paul Muna [1 ]
Fung, Brian M. [1 ]
Zucker, Kelly [1 ]
David, Joseph [1 ]
机构：
[1] Univ Arizona, Coll Med, Phoenix, AZ USA
[2] Univ Arizona, Phoenix, AZ USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2021年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1696
引用
收藏
页码：S756 / S756
页数：1
相关论文
共 50 条
  • [1] Vedolizumab for steroid & infliximab refractory immune checkpoint inhibitor associated colitis
    Klemm, Natasha
    Trasolini, Roberto
    Chahal, Daljeet
    Donnellan, Fergal
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (04)
  • [2] CMV coinfection in treatment refractory immune checkpoint inhibitor colitis
    Harris, Kevin B.
    Funchain, Pauline
    Baggott, Brian B.
    [J]. BMJ CASE REPORTS, 2020, 13 (05)
  • [3] Vedolizumab in the treatment of immune checkpoint inhibitor-induced colitis: Two case reports
    Zhang, Zhe
    Zheng, Chang-Qing
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (29) : 10550 - 10558
  • [4] Vedolizumab in the treatment of immune checkpoint inhibitor-induced colitis: Two case reports
    Zhang, Zhe
    Zheng, Chang-Qing
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12 : 10550 - 10558
  • [5] A case of refractory immune checkpoint inhibitor-induced colitis improved by the treatment with vedolizumab and granulocyte–monocyte apheresis combination therapy
    Hikaru Ishihara
    Tatsuyuki Watanabe
    Shinsuke Kumei
    Keiichiro Kume
    Ichiro Yoshikawa
    Masaru Harada
    [J]. Clinical Journal of Gastroenterology, 2024, 17 : 46 - 51
  • [6] Biologic Therapy for Refractory Immune Checkpoint Inhibitor Colitis
    Alorfi, Nasser M.
    Alourfi, Mansour Marzouq
    [J]. BIOLOGICS-TARGETS & THERAPY, 2022, 16 : 119 - 127
  • [7] A case of refractory immune checkpoint inhibitor-induced colitis improved by the treatment with vedolizumab and granulocyte-monocyte apheresis combination therapy
    Ishihara, Hikaru
    Watanabe, Tatsuyuki
    Kumei, Shinsuke
    Kume, Keiichiro
    Yoshikawa, Ichiro
    Harada, Masaru
    [J]. CLINICAL JOURNAL OF GASTROENTEROLOGY, 2024, 17 (01) : 46 - 51
  • [8] Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis
    Viktoria Bergqvist
    Erik Hertervig
    Peter Gedeon
    Marija Kopljar
    Håkan Griph
    Sara Kinhult
    Ana Carneiro
    Jan Marsal
    [J]. Cancer Immunology, Immunotherapy, 2017, 66 : 581 - 592
  • [9] Efficacy of Infliximab and Vedolizumab in Immune Checkpoint Inhibitor Colitis: A Meta-Analysis
    Zuberi, Shaharyar
    Anderson, Kelsey
    Porth, Rachel
    Taneja, Vikas
    Feuerstein, Joseph D.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S229 - S231
  • [10] Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis
    Bergqvist, Viktoria
    Hertervig, Erik
    Gedeon, Peter
    Kopljar, Marija
    Griph, Hakan
    Kinhult, Sara
    Carneiro, Ana
    Marsal, Jan
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (05) : 581 - 592
12345